Figure S1 --Unbiased Fo-Fc electron density of calcium ions. Profilaggrin crystal asymmetric unit (top; two dimers) in light blue with the eight bound calcium ions as green spheres. Depicted in green wire mesh is the Fo-Fc electron density contoured at 3σ. Pictured at the bottom right within the red zoom box is the canonical EF-hand in the C subunit, showing classic canonical EF-hand calcium coordination (residues labeled) and the Fo-Fc electron density in green (contoured at 3σ).
--Calcium coordination. Profilaggrin, belonging to the S100 fused-type protein family, contains two types of EF-hands: an N-terminal pseudo/S100 (non-canonical) calcium binding loop (top) and a C-terminal canonical calcium binding loop (bottom). The profilaggrin sequence for each calcium binding loop in the N-terminal calcium binding domain is depicted, along with a position number. The type of calcium coordination for each position within the calcium binding loop is described for both types of calcium binding sites (pseudo/S100/non-canonical vs canonical). Images from the x-ray structure depict the pseudo/S100 (top) and canonical (bottom) calcium coordination for profilaggrin's N-terminus.
Canonical and Pseudo/S100 Calcium Binding Loops in Pro laggrin Crystal Structure
Pro laggrin Pseudo/S100 Calcium Binding Loop
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Position-1 2 3 4 5 6 7 8 9 10 11 12 13 14 Human profilaggrin constructs containing either the S100 calcium-binding A domain, B domain or complete N-terminus (A + B domains) prepared in the bait (DNA binding domain) vector (green) or prey (activation domain) (pink) were transformed into yeast, and cells grown on either histidine, leucine and tryptophan (HLT)-deficient media containing 3-amino 1,2,4-triazole (3-AT) (a, c) or leucine and tryptophan(LT)-deficient media as a control (b). Panel (a), bait and prey combinations grown on HLT-deficient containing 5 mM 3-AT. Only the complete terminus (hAB) and the control protein S100A2 formed homodimers in yeast under these selective conditions. Neither human profilaggrin domain A (hA, amino acids 1-91) or B (hB, amino acids 91-293) formed homodimers in yeast. The human AB protein also did not interact with either human S100A2 or yeast MEC3 used as controls. Panel (b), the same bait and prey combinations grown on LT-deficient media, showing robust growth and colony formation. Panel (c), bait and prey human profilaggrin terminus constructs grown on HLT-deficient media with 5 mM 3-AT. Note that the only profilaggrin combinations that interacted in yeast were the AB-293 homodimer containing the complete N-terminus, and the AB-293 in combination with a slightly truncated binding partner, AB-259. The number indicates the number of residues contained in the bait or prey fusion protein. All of the construct combinations grew to confluence on control (LT-deficient) media. Figure S6 . Schematics of constructs used for yeast-two-hybrid analysis of profilaggrin N-terminus homodimerization and N-terminus-annexin II interaction.
Pro laggrin Canonical Calcium Binding Loop
Profilaggrin A constructs contain just the S100 domain (residues 1-92), while full-length AB constructs include the complete N-terminus (residues 1-293); additional AB constructs included various truncations made within the B domain, e.g. at residues -98, -120, -140, -160, -218, and -259. Annexin II (ANXA2) consists of 4 annexin repeats of 70 amino acids (light blue boxes) flanked by N-terminal and C-terminal domains (unshaded boxes). The N-terminal domain of 32 residues includes amino acids 1-14 (shaded black box) that interact with the profilaggrin N-terminus and S100A10.
Annexin II (human)
ANXA2
(1-339)
(15-339)
(1-44) (Top left) 24 residues (orange) comprise the hydrophobic pocket of one PF-CABD protein, with bound PEG 400 shown as ball and stick model (carbon, white; oxygen, red).
(Top right) Ile43 and Leu44 (side chains orange) contact PEG 400 (carbon, white; oxygen, red), resulting in a folded conformation of inter-EF-hand linker (L). Wire diagram of PF-CABD monomer (gray) with inter-EF-hand linker (orange).
Bound PEG 400 (by-product of cryocrystallography) alludes to the CABD functioning as a target-binding site. Of 24 residues comprising the hydrophobic pocket, 16 interacted with PEG 400 based on analysis of both the "A" and "C" PF-CABD subunits from the crystal AU (Table S2 ). The "B" and "D" subunits did not contain PEG. Interestingly, only "A" and "C" subunits have linkers between Helix II and Helix III in a "folded" rather than "extended" conformation. Ile43 and Leu44 are positioned centrally in this linker and in the structure contact PEG 400 (above right), suggesting this flexible linker functions to stabilize target interactions. Linker folding likely explains the slightly more "closed" Helix I/II orientation for the "A" and "C" subunits (Table S1 ).
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MSTLL-ENIF AIINLFKQYS KKDKNTDTLS KKELKELLEK EFRQILKNPD DPDMVD-VFM DHLDIDHNKK IDFTEFL-LM VFKLAQAYYE STRKE --TKLEEHLE GIVNIFHQYS VRKGHFDTLS KGELKQLLTK ELANTIKNIK DKAVIDEIFQ G-LDANQDEQ VDFQEFISLV AIALKAAHYH
hS100A12 ( Clustal Omega multiple sequence alignment (top) of the N-termini of 7 epidermal S100 fused-type proteins as well as calbindin D9k, calmodulin, S100B and S100A12. h = human; m = mouse; b = bovine. Completely conserved residues are colored purple and denoted by (*). Highly conserved residues are colored green and denoted (:). Moderately conserved residues are colored orange and denoted by (.). The numbering across the top represents the amino acid sequence numbering for the crystal structure of profilaggrin N-terminus, not positioning for all aligned sequences. The 24 amino acid residues contributing accessible surface area to profilaggrin's N-terminal hydrophobic pocket have a yellow-shaded background; the shading is extended across the multiple sequence alignment to illustrate differences among the protein sequences.
Swiss-Model structural alignment (bottom) between the crystal structure of the N-terminus of human profilaggrin (PDB Code 4PCW) and human S100A12(PDB Code 1E8A), the latter being the model used for molecular replacement. For the profilagrin structure, helices are labeled and colored blue, whereas calcium-binding loops are labeled and colored red. Table 2 . Stratifin interacts with profilaggrin N-terminus in yeast.
Combinations of bait (green) and prey (pink) fusion proteins were transformed into yeast and grown on HLT-deficient media containing 10 mM 3-AT. Human stratifin (SFN) interacts with full length human profilaggrin N-terminus (hum AB), but not the human A domain (hum A), while SFN interacts with the mouse A and B domains (mou A, B and AB). SFN also gave a similar interaction signal with a mutant human profilaggrin N-terminus protein carrying selected mutations within the calcium-binding domain (hum mut AB). All of the construct combinations grew to confluence on control (LT-deficient) media. Please also see Supplemental Discussion related to this figure. molecularly docked onto the PF-CABD dimer structure using the Hex Protein Docking server (http://hexserver.loria.fr/). The structure of the annexin II N-terminus used for docking was dervied from Protein Data Bank Code 1BT6. The sequence di ers from human annexin II by a cysteine (human) to serine (chicken) substitution at position 8. Pictured at the bottom is the PF-CABD dimer (light and dark blue) with the annexin II N-terminal helix colored red (the six residues highlighted in orange are the annexin II residues that interact with the PF-CABD binding pocket. In the zoomed in image (top), the seven PF-CABD residues within the hydrophobic pocket that interact with annexin II are highlighted yellow and labeled. 
PF-CABD
Supplemental Data -Tables
. Amino Acid Residues Surrounding the Target Binding
Pocket and associated Accessible Surface Area. The asterisks (*) denote residues contacting the bound PEG 400 molecule in either the "A" or "C" subunit from the crystal asymmetric unit. The five residues conserved across the S100 fused-type protein family are denoted (italics, #). A, B, C, D = subunits from the crystal asymmetric unit. a cDNAs were prepared using the common upstream primer combined with various downstream primers. b Construct names are designated by the C-terminal amino acid present in the expressed protein; for simplicity, engineered restriction sites used for DNA cloning are not shown. c Full length human stratifin lacking an initiation codon (247 amino acids) was cloned into the Y2H vectors pOBD and pOAD. Table S6 . Profilaggrin Protein Production and Purification Protocol. 1 Human profilaggrin N-terminal calcium binding domain (PF-CABD) was expressed in Escherichia coli strain BL21 (DE3) Codon + RIPL (Agilent Technologies) at 37 o C in Luria Broth Miller (EMD Millipore). 2 Protein expression induced with 1 mM isopropyl-D-thiogalactopyranoside (IPTG) proceeded for 3-4 hours. 3 Cells were harvested by centrifugation at 2500 x g, 10 min., at 4 o C. 4 The pelleted cells were suspended in 50 mM Tris-HCl buffer (pH 7.8) containing 0.5 M NaCl, 20 mM imidazole, 6 mM MgCl 2 , 1% Nonidet P-40, and 1x EDTA-free protease inhibitor cocktail (Roche Diagnostics). 5 Cell lysis was achieved by sonication on ice, followed by incubating the solution with ~ 40 units/mL DNase I at 37 o C for 15 min. 6 The solution was centrifuged at 14000 x g, 15 min, at 4 o C. 7 The supernatant containing soluble PF-CABD was decanted into a 50 mL centrifuge tube (Corning) containing 5 mL of nickel-NTA agarose (Qiagen) washed with 50 mM Tris-HCl buffer (pH 7.8) containing 0.5 M NaCl and 20 mM imidazole for "batch method" His-tag purification. 8 The solution and nickel resin were incubated for ~ 1 hr at 4 o C with gentle rocking. 9 The resin was pelleted by centrifugation at 700 x g, 5 min, 4 o C, and the solution decanted. 10 The resin was suspended in 30 mL of 50 mM Tris-HCl buffer (pH 7.8) containing 0.5 M NaCl and 20 mM imidazole, allowed to "wash" for 10-15 min. at 4 o C with gentle rocking, then the resin was pelleted again at 700 x g, 5 min., at 4 o C with decanting of the supernatant. 11 The wash cycle was repeated a second time, after which the pelleted nickel resin containing bound His-tagged PF-CABD was incubated overnight with 15.2 µg (34 units) bovine alpha-thrombin (Haematologic Technologies, Inc.) at 20 o C to remove the His-tag. 12 The following morning the resin was suspended to 5 mL with 50 mM Tris-HCl buffer (pH 7.8) containing 0.5 M NaCl and 20 mM imidazole, and syringe-filtered through a 0.45 µm filter (EMD Millipore) to remove the nickel resin bound to Histag. 13 The clarified solution containing the untagged PF-CABD was applied to a Superdex 75 (26/60) gel filtration column for further purification in either 50 mM Tris-HCl buffer (pH 7.8) containing 0.5 M NaCl and 5 mM CaCl 2 (size exclusion chromatography experiments) or 50 mM Tris-HCl buffer (pH 7.8) containing 0.5 M NaCl and 1 mM EDTA (size exclusion chromatography, light scattering, crystallization experiments). 14 Collected fractions were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and selected pooled fractions were concentrated in a 3000 Da molecular weight cutoff centrifugal filter unit (EMD Millipore) prior to crystallization.
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Profilaggrin constructs
For Y2H, human profilaggrin N-terminal constructs containing the A (S100) domain, B domain or A domain plus varying amounts of the B domain were prepared using PCR and DNA cloning into the pOBD and pOAD vectors (Yeast Resource Center, University of Washington) (Hudson et al., 1997) (Table S5 ). For crystallization, PF-CABD (A domain, human profilaggrin residues 1-92 inclusive of N-terminal methionine) was purchased from GenScript (Piscataway, NJ) (transformed into plasmid pGS-21a)
containing N-terminal 6x-histidine tag with thrombin cleavage site. PF-CABD was sequence verified by DNA sequencing at the Keck Biotechnology Resource Laboratory (Yale University, New Haven, CT). Mouse profilaggrin N-terminal constructs encoding 99 amino acids (A domain) and 283 amino acids (A and B domains) were prepared as described (Yoneda et al., 2012) .
Annexin II (p36) and stratifin constructs
Full length human cDNA for annexin II (p36) was generated by RT-PCR from foreskin cDNA with customized primers using standard procedures (Presland et al., 2000) and the DNA products cloned into TOPO-TA vector (Life Technologies, Grand Island, NY) (Table S5) . A human stratifin (14-3-3sigma) cDNA clone was obtained from Dr. Michael
Yaffe (MIT, Boston) (Table S5 ). All PCR products were cloned in-frame into the Y2H vectors pOBD and pOAD; miniprep plasmid DNA was sequence verified prior to Yeast two-hybrid assays and expression analysis.
Plasmids were transformed into yeast strain PJ694A (Yeast Resource Center) using a commercial yeast transformation kit (Zymo Research, Orange, CA) as described previously (Yoneda et al., 2012) . Double-transformed yeast stocks containing pOBD and pOAD plasmids were maintained on tryptophan and leucine-deficient yeast (LT) plates.
For yeast two-hybrid assays, cells were plated on histidine-deficient plates (also lacking tryptophan and leucine, designated HLT plates) containing between 2.5 and 20 mM 3-amino-1,2,4-triazole (3-AT) (Sigma-Aldrich, St. Louis, MO) and grown at 30 ºC.
For protein expression analysis, yeast cells containing either one or two plasmids were grown overnight in selective yeast media (lacking either leucine, or leucine and tryptophan) and yeast protein lysates were prepared using glass beads, as recommended by Clontech (Palo Alto, CA). Alternatively, yeast cells were pelleted in a microfuge and directed lysed into SDS loading buffer, prior to loading on SDS/polyacrylamide gels (Warner et al., 2000) . SDS/PAGE and Western blotting of yeast lysates (~25 µg/lane) were performed as described previously, using either human profilaggrin N-terminal antibodies to assess the expression of bait and prey hybrid proteins. Immunoblots were developed by ECL using SuperSignal West Pico substrate (ThermoFisher Scientific, Rockford, IL). A human foreskin Urea/Tris extract was used as a positive control for immunoblots.
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Immunoprecipitation and mass spectrometry.
Human neonatal foreskin epidermis was separated from underlying dermis and homogenized in a modified RIPA buffer containing 1% Nonidet P-40 (Pearton et al., 2001) . Human profilaggrin B1 antibody (Presland et al., 1997) or an irrelevant polyclonal IgG control antiserum (10 µg) was conjugated to 100 ml of protein A-conjugated profilaggrin A or B1 antibody as described (Presland et al., 1997) .
The remainder of the immunoprecipitate was separated on a 7.5-12.5% SDS/polyacrylamide gel and stained with Coomassie Brilliant Blue (CBB) solution.
Protein bands were excised from the gel, destained, and in-gel digested with mass spectrometry grade trypsin (Sigma) (Shevchenko et al., 1996) . Peptides were eluted from the gel, dried in a Speedivac and the mixtures analyzed using a triple quadrupole mass spectrometer (TSQ 7000, Finnegan Mat, San Jose, CA) with an in-house fabricated electrospray source and a HP 1100 solvent delivery system (Hewlett Packard, Palo Alto, Page 50 of 57 CA). Peptide identification was obtained from collision-induced dissociation mass spectra using SEQUEST (The Scripps Research Institute, La Jolla, CA).
Immunoprecipitation experiments to confirm protein-protein interactions in tissue lysates were performed as described previously (Pearton et al., 2002) , except that in some cases 5 mM CaCl 2 or 5 mM EDTA was added to the incubation containing primary antibody and tissue lysate. Immunoprecipitated proteins were eluted from protein A-conjugated paramagnetic beads as described above, and the entire eluate was run on SDS/polyacrylamide gels, transferred to PVDF membrane and immunoblotted with antibody.
Immunofluorescence microscopy.
For immunolocalization studies, human adult skin was cryosectioned at a thickness of 6 µm and fixed in 4% paraformaldehyde. Sections were immunolabeled with a rabbit antibody to human profilaggrin (B1)(1:1000) and a goat antibody to human stratifin
(1:16) as described (Presland et al., 1997; Underwood et al., 2009) . After labeling with primary antibodies, sections were subsequently labeled with a biotinylated donkey antigoat IgG and streptavidin-Texas Red to visualize stratifin, and a donkey anti-rabbit IgG conjugated with fluorescein isothiocyanate (Jackson ImmunoResearch, West Grove, PA) to visualize profilaggrin. Tissue sections were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) to identify nuclei. Tissue sections were visualized using a Nikon Microphot-SA upright microscope equipped with both transmitted and epi-fluorescence illumination (Nikon Instruments; Melville, NY). Images were acquired using a 
Statement on Use of Human Materials.
Normal human neonatal and adult skin, utilized for immunofluorescence microscopy and immunoprecipitation studies, were obtained through the Division of Dermatology with approval from the University of Washington Institutional Review Board.
